Überblick über die Statistik des Gehaltsniveaus für "Corporate Investigator in Deutschland"

OUR IMPACT Our division prevents, detects and mitigates compliance, regulatory and reputational risk across the firm and helps to strengthen the firm’s culture of compliance. Compliance accomplishes these through the firm’s enterprise-wide compliance risk management program. As an independent control function and part of the firm’s second line of defense, Compliance assesses the firm’s compliance, regulatory and reputational risk; monitors for compliance with new or amended laws, rules and regulations; designs and implements controls, policies, procedures and training; conducts independent testing; investigates, surveils and monitors for compliance risks and breaches; and leads the firm’s responses to regulatory examinations, audits and inquiries. You'll be part of a team with members from a wide range of academic and professional backgrounds, such as law, accounting, sales, and trading. We look for those who possess sound judgment, curiosity, and are able to adapt to a changing regulatory landscape. Financial Crime Compliance (“FCC”) has primary responsibility for the execution of the firm’s enterprise-wide Anti-Money Laundering (“AML”), anti-bribery, and government sanctions compliance programs and, among other things, performs enhanced due diligence and government sanctions screening, as well as surveillance and investigations designed to identify potential terrorist financing, money laundering, bribery, market abuse, or other suspicious activity. YOUR IMPACT FCC is seeking an individual to join its FCC Transaction Banking - Transaction Investigations team (FCC TxB Investigations). FCC TxB Investigations is seeking an Analyst, ideally with corporate banking and / or other financial industry experience. The Analyst will conduct in-depth transactional investigations to identify AML red flags probative of potential illicit activity. When problematic transactions are identified, the investigator will take the appropriate steps to escalate, discontinue, and/or mitigate such activity. The ideal candidate would have strong analytical skills, the ability to collaborate with others, the ability to manage projects and processes, and the ability to multi-task. In this role, the Analyst will work closely with Compliance, Operations, Engineering and Business personnel, and would be expected to quickly gain an understanding of the firm's businesses and the rules and regulations under which it operates. Principal Responsibilities: Review transaction surveillance alerts and conduct case investigations to identify potential suspicious activity for reporting purposes Identify patterns and trends consistent with money laundering, terrorist financing, and other types of suspicious activity. Completion of daily tasks and supporting projects to meet the overall department goals in line with the firm’s AML program. Support various AML & Fraud processes, including but not limited to, transaction activity reviews, suspicious activity, fraud referral, investigations, fulfillment of information sharing and law enforcement requests. Filing of Suspicious Activity Reports (“SAR”). Preferred Qualifications: Ability to work independently and in team-oriented workflows Collaborative and team player Strong analytical and risk assessment skills Excellent written and verbal communication skills Ability to prioritize workflows and ensure deadlines are met Ability to forge strong relationships with colleagues and clients Proactive, self-motivated, detail-oriented and well-organized Prior Compliance / AML experience would be a bonus Awareness of EU/UK AML Regulations 2-5 years of experience preferred ABOUT GOLDMAN SACHS At Goldman Sachs, we commit our people, capital and ideas to help our clients, shareholders and the communities we serve to grow. Founded in 1869, we are a leading global investment banking, securities and investment management firm. Headquartered in New York, we maintain offices around the world. We believe who you are makes you better at what you do. We're committed to fostering and advancing diversity and inclusion in our own workplace and beyond by ensuring every individual within our firm has a number of opportunities to grow professionally and personally, from our training and development opportunities and firmwide networks to benefits, wellness and personal finance offerings and mindfulness programs. Learn more about our culture, benefits, and people at /careers. We’re committed to finding reasonable accommodations for candidates with special needs or disabilities during our recruiting process. Standort Goldman Sachs, Frankfurt

Open for hire at one of the following locations – Mainz Goldgrube. - Job ID: 5703 Become a member of the BioNTech Family!As a part of our team of more than 5.000 pioneers, you will play a key role in developing solutions for some of the most crucial scientific challenges of our age. Within less than a year, we were able to develop our COVID-19 mRNA vaccine following the highest scientific and ethical standards – writing medical history. We aim to reduce the suffering of people with life-changing therapies by harnessing the potential of the immune system to develop novel therapies against cancer and infectious diseases. While doing so, we are guided by our three company values: united, innovative, passionate. Get in touch with us if you are looking to be a part of creating hope for a healthy future in many people's lives. Associate Director* Translational Sciences (limited to 12 months) Key responsibilities Collaborating with a Translational Lead on the development and implementation of program-specific, integrated biomarker strategies from Ph1 to licensure, in alignment with clinical development objectivesContributing to the translation of preclinical results and approaches to clinical biomarker strategies supporting efficient clinical development of the assigned infectious disease assets through data-driven decision making and regulatory complianceAs a member of the cross-functional translational sub-team, partnering with clinical, technical, and scientific colleagues to contribute to the overall biomarker strategy and assist in its executionProvides biomarker and translational contributions to the integrated development plan, clinical development plan, and to regulatory study- or program-related documents such as clinical trial protocols, and -reports, investigator brochures, briefing documents, and market authorization applicationsContributes to the execution of the translational and biomarker strategy in the assigned development program(s) What you have to offer PhD, PharmD, or MD/PhD in Immunology, Biology, Biochemistry, Molecular Medicine, Virology, or a related field with

Help us change livesAt Exact Sciences, we’re helping change how the world prevents, detects and guides treatment for cancer. We give patients and clinicians the clarity needed to make confident decisions when they matter most. Join our team to find a purpose-driven career, an inclusive culture, and robust benefits to support your life while you’re working to help others.Company OverviewExact Sciences is dedicated to delivering patient critical answers across the cancer journey from early detection to treatment decision making. With a strong focus on people and an empathetic spirit, which fuels the company’s culture, driving them to create and deliver solutions rooted in the needs of patients, providers, and families. From earlier cancer detection to treatment guidance and monitoring, Exact Sciences are helping people get the answers they need to make more informed decisions across the cancer continuum. With a leading portfolio of products for earlier detection and treatment guidance, they help people face the most challenging decisions with confidence with a dedication to continuously innovate, combining scientific rigor with an open-minded approach to deliver the next big thing.Exact Sciences is continuously expanding the pipeline with the aim of tackling a wider array of cancer tests through the following measures:Expanding the Oncotype IQ platform to include liquid and tissue-based tests, all with the goal of making cancer care smarter.Adapting biomarker-based technologies create a liquid biopsy capable of detecting cancers and precancers from a blood sample.Using their proven multi-marker approach to achieve analytical sensitivity needed to discriminate between normal and cancerous samples.Collaborating with world-class clinicians and scientists at Mayo Clinic to identify biomarkers associated with the 15 deadliest cancers.Building a cancer detection platform upon learnings from the development of Cologuard (commercially available in the US only).By 2020, Oncotype DX will have been used to guide treatment decisions for more than 1 million cancer patients worldwide in breast, prostate and colon cancer.In July 2019 Exact Sciences acquired Genomic Health, a genetic cancer detection company based in Redwood City, California, for USD 2.8 billion, creating the leading global cancer diagnostics company.In 2020 Exact Sciences acquired Thrive Earlier Detection Corp., a Massachusetts-based healthcare company, in a multi-billion-dollar deal, and Base Genomics, which has technology for DNA methylation analysis.In February 2021 Exact Sciences announced the acquisition of Ashion Analytics, LLC (Ashion) from The Translational Genomics Research Institute (TGen), an affiliate of City of Hope. Ashion is a CLIA-certified and CAP-accredited sequencing lab based in Phoenix, Arizona with the genomics testing capabilities necessary to address the increasingly complex needs of clinical, academic, and biopharma customers focused on precision cancer treatments.The company is based in the United States, with International headquarters in Zug, Switzerland. Position SummaryThe Medical Affairs Senior Manager, MSL & Expansion Markets, France is a hybrid role responsible for leading an international team of Medical Science Liaisons and supporting Exact Sciences International expansion strategy with key medical activities.This is an exciting chance to build the first Exact Sciences International MSL team in leading and executing an efficient and transparent conversion plan to bring MSL contractors in-house as well as hire and onboard new MSLs to create a diverse and inclusive team. The International Medical Affairs Senior Manager – MSL & Expansion Markets will be expected to develop and drive MSL strategy ensure field medical activities and insight generation result in demonstrable outcomes and further develop and grow the MSL capability at Exact Sciences International.In addition, this individual will be responsible for medical affairs activities in selected key markets across International. These markets will include those where we want to move directly into a market (currently through distributors) or those markets where we currently have limited patient access that require improved reimbursement pathways.The Medical lead will work closely with the Market Expansion Team and lead all associated medial activities that may include leading medical activities for change in market reimbursement, aligning new market needs with central medical team, developing core data strategy for new markets, and defining resourcing needs and transition to new hires. The position is also responsible for consolidating and interpreting medical intelligence and reporting it to the Expansion Markets team.The incumbent will work closely with other functions within the company, including Corporate Strategy, Marketing, and Commercial to advance cross-functional understanding of the MSL value proposition, identify gaps and achieve results in line with company objectives.Representing the medical function, this individual will also manage research and educational medical objectives, while supporting commercial business and reimbursement objectives for the Oncotype DX breast recurrence score test.This position requires professionals with established personal and scientific creditability to interact with thought leaders, government health authorities, and medical centers of excellence. This is a dynamic role and will continue to evolve.Responsibilities/DutiesLead an international team of MSLs toward the implementation of field medical activities by communicating expectations and guiding the team to maintain and effectively communicate deep scientific knowledge and excel at KOL engagement and support medical/scientific information needs of scientific and clinical experts.Accompany the team to meetings with KOLs and other HCPs to assess proficiency and provide timely and constructive performance feedback.Lead and coordinate MSL team meetings to support team building, best practice sharing, development, and the accomplishment of field medical objectives.Develop a MSL Strategic Plan as well as Medical Plan for the markets, which include plans for KOL engagement, data generation, educational and guideline initiatives and reimbursement initiatives that align with the business objectives.Identify and engage international, national, and regional thought leaders in breast cancer within assigned geographic regions to conduct scientific discussions and understand insights related to molecular diagnostics in early BC management, while also establishing and maintaining professional relationships with them.Act as primary contact for investigators interested in developing and performing studies with the company’s commercially available assays in breast cancer.Assist in R&D and investigator-initiated studies as appropriate.Lead national and regional Advisory Boards when external advice is needed.Provide clinical presentations and information in academic, community, and healthcare provider setting in both group and one-on-one situations.Support & partner with regional team to deliver key medical activities.Developing medical slides, giving medical training presentations, and training in internal meetings and for partner distributors.Support international access & reimbursement with medical and scientific expertise.Assure compliance with relevant corporate policies.Provide feedback and medical input to local commercial plans and strategies.Pivotal Experience & ExpertiseDegree in Medicine/Medical Doctor or PhD, PharmD.3+ years of therapeutic clinical experience desired.5 to 7 years of industry experience (working in pharma/biotech/med tech).At least 3 years in a Medical Science Liaison role.Previous MSL (or other) management experience.Expertise in Oncology. Experience in breast/GI/lung cancer is a plus.Experience in Diagnostics or Biotech industry is a plus.Experience in relevant geographies a plus.Excellent English. Skills in other languages preferred.Excellent oral, written and presentation communication skills.Ability to independently deliver quality results in a timely manner.Proven record of working in matrix environment and delivering as part of a cross-functional team.Track record of delivering innovative medical activities across markets.Cultural ImpactHighest integrity and ethical behavior.Mutual respect for colleagues.Collaborative within teams, uses resources carefully and can build a great place to work and grow.Ability to interact within culturally diverse teams.Business acumen and innovative mindset. Ability to manage though complexity and ambiguity, while focusing on the end goal.OtherOffice-based in the International headquarters in Zug or out of one of our European offices.Ability to travel approx.. >50%.#LI-TK1Our success relies on the experiences and perspectives of a diverse team, and Exact Sciences fosters a culture where all employees can develop personally and professionally with a sense of respect and belonging. If you require an accommodation, email E-Mail anzeigen. We’ll work with you to meet your accessibility needs.Not ready to apply? Join our talent community and stay up to date on what’s new at Exact Sciences. Standort PreventionGenetics, Munich

Help us change livesAt Exact Sciences, we’re helping change how the world prevents, detects and guides treatment for cancer. We give patients and clinicians the clarity needed to make confident decisions when they matter most. Join our team to find a purpose-driven career, an inclusive culture, and robust benefits to support your life while you’re working to help others.Company OverviewExact Sciences is dedicated to delivering patient critical answers across the cancer journey from early detection to treatment decision making. With a strong focus on people and an empathetic spirit, which fuels the company’s culture, driving them to create and deliver solutions rooted in the needs of patients, providers, and families. From earlier cancer detection to treatment guidance and monitoring, Exact Sciences are helping people get the answers they need to make more informed decisions across the cancer continuum. With a leading portfolio of products for earlier detection and treatment guidance, they help people face the most challenging decisions with confidence with a dedication to continuously innovate, combining scientific rigor with an open-minded approach to deliver the next big thing.Exact Sciences is continuously expanding the pipeline with the aim of tackling a wider array of cancer tests through the following measures:Expanding the Oncotype IQ platform to include liquid and tissue-based tests, all with the goal of making cancer care smarter.Adapting biomarker-based technologies create a liquid biopsy capable of detecting cancers and precancers from a blood sample.Using their proven multi-marker approach to achieve analytical sensitivity needed to discriminate between normal and cancerous samples.Collaborating with world-class clinicians and scientists at Mayo Clinic to identify biomarkers associated with the 15 deadliest cancers.Building a cancer detection platform upon learnings from the development of Cologuard (commercially available in the US only).By 2020, Oncotype DX will have been used to guide treatment decisions for more than 1 million cancer patients worldwide in breast, prostate and colon cancer.In July 2019 Exact Sciences acquired Genomic Health, a genetic cancer detection company based in Redwood City, California, for USD 2.8 billion, creating the leading global cancer diagnostics company.In 2020 Exact Sciences acquired Thrive Earlier Detection Corp., a Massachusetts-based healthcare company, in a multi-billion-dollar deal, and Base Genomics, which has technology for DNA methylation analysis.In February 2021 Exact Sciences announced the acquisition of Ashion Analytics, LLC (Ashion) from The Translational Genomics Research Institute (TGen), an affiliate of City of Hope. Ashion is a CLIA-certified and CAP-accredited sequencing lab based in Phoenix, Arizona with the genomics testing capabilities necessary to address the increasingly complex needs of clinical, academic, and biopharma customers focused on precision cancer treatments.The company is based in the United States, with International headquarters in Zug, Switzerland. Position SummaryThe Medical Affairs Senior Manager, MSL & Expansion Markets, France is a hybrid role responsible for leading an international team of Medical Science Liaisons and supporting Exact Sciences International expansion strategy with key medical activities.This is an exciting chance to build the first Exact Sciences International MSL team in leading and executing an efficient and transparent conversion plan to bring MSL contractors in-house as well as hire and onboard new MSLs to create a diverse and inclusive team. The International Medical Affairs Senior Manager – MSL & Expansion Markets will be expected to develop and drive MSL strategy ensure field medical activities and insight generation result in demonstrable outcomes and further develop and grow the MSL capability at Exact Sciences International.In addition, this individual will be responsible for medical affairs activities in selected key markets across International. These markets will include those where we want to move directly into a market (currently through distributors) or those markets where we currently have limited patient access that require improved reimbursement pathways.The Medical lead will work closely with the Market Expansion Team and lead all associated medial activities that may include leading medical activities for change in market reimbursement, aligning new market needs with central medical team, developing core data strategy for new markets, and defining resourcing needs and transition to new hires. The position is also responsible for consolidating and interpreting medical intelligence and reporting it to the Expansion Markets team.The incumbent will work closely with other functions within the company, including Corporate Strategy, Marketing, and Commercial to advance cross-functional understanding of the MSL value proposition, identify gaps and achieve results in line with company objectives.Representing the medical function, this individual will also manage research and educational medical objectives, while supporting commercial business and reimbursement objectives for the Oncotype DX breast recurrence score test.This position requires professionals with established personal and scientific creditability to interact with thought leaders, government health authorities, and medical centers of excellence. This is a dynamic role and will continue to evolve.Responsibilities/DutiesLead an international team of MSLs toward the implementation of field medical activities by communicating expectations and guiding the team to maintain and effectively communicate deep scientific knowledge and excel at KOL engagement and support medical/scientific information needs of scientific and clinical experts.Accompany the team to meetings with KOLs and other HCPs to assess proficiency and provide timely and constructive performance feedback.Lead and coordinate MSL team meetings to support team building, best practice sharing, development, and the accomplishment of field medical objectives.Develop a MSL Strategic Plan as well as Medical Plan for the markets, which include plans for KOL engagement, data generation, educational and guideline initiatives and reimbursement initiatives that align with the business objectives.Identify and engage international, national, and regional thought leaders in breast cancer within assigned geographic regions to conduct scientific discussions and understand insights related to molecular diagnostics in early BC management, while also establishing and maintaining professional relationships with them.Act as primary contact for investigators interested in developing and performing studies with the company’s commercially available assays in breast cancer.Assist in R&D and investigator-initiated studies as appropriate.Lead national and regional Advisory Boards when external advice is needed.Provide clinical presentations and information in academic, community, and healthcare provider setting in both group and one-on-one situations.Support & partner with regional team to deliver key medical activities.Developing medical slides, giving medical training presentations, and training in internal meetings and for partner distributors.Support international access & reimbursement with medical and scientific expertise.Assure compliance with relevant corporate policies.Provide feedback and medical input to local commercial plans and strategies.Pivotal Experience & ExpertiseDegree in Medicine/Medical Doctor or PhD, PharmD.3+ years of therapeutic clinical experience desired.5 to 7 years of industry experience (working in pharma/biotech/med tech).At least 3 years in a Medical Science Liaison role.Previous MSL (or other) management experience.Expertise in Oncology. Experience in breast/GI/lung cancer is a plus.Experience in Diagnostics or Biotech industry is a plus.Experience in relevant geographies a plus.Excellent English. Skills in other languages preferred.Excellent oral, written and presentation communication skills.Ability to independently deliver quality results in a timely manner.Proven record of working in matrix environment and delivering as part of a cross-functional team.Track record of delivering innovative medical activities across markets.Cultural ImpactHighest integrity and ethical behavior.Mutual respect for colleagues.Collaborative within teams, uses resources carefully and can build a great place to work and grow.Ability to interact within culturally diverse teams.Business acumen and innovative mindset. Ability to manage though complexity and ambiguity, while focusing on the end goal.OtherOffice-based in the International headquarters in Zug or out of one of our European offices.Ability to travel approx.. >50%.#LI-TK1Our success relies on the experiences and perspectives of a diverse team, and Exact Sciences fosters a culture where all employees can develop personally and professionally with a sense of respect and belonging. If you require an accommodation, email E-Mail anzeigen. We’ll work with you to meet your accessibility needs.Not ready to apply? Join our talent community and stay up to date on what’s new at Exact Sciences. Standort PreventionGenetics, Cologne

Abiomed is an innovative medical device business with an inspiring mission "Patients First" and a unique guiding company principle "Recovering hearts. Saving lives." With more than 2,000 employees, Abiomed is one of the fastest growing medical technology businesses in the world with corporate headquarters in Danvers, USA, and locations in Aachen and Berlin, Germany, Tokyo, Japan, and Singapore. Abiomed is part of Johnson & Johnson MedTech.Abiomed is an employer with attractive working conditions and an appreciative corporate culture that focuses on the needs of its employees. Abiomed inspires and retains exceptional talent through collaboration, passion and continuous development.Clinical Trial CoordinatorThe Clinical Trial Coordinator (CTC) supports Clinical Project and Program Managers in planning and coordinating activities in all aspects of clinical trial operations. This position requires appropriate interpretation of significant policies and procedures. It involves interaction with internal and external customers and partners, and must operate with a high degree of discretion, as the role involves handling information of a confidential and critical nature.Main tasks and responsibilities:Plan, coordinate, and arrange study communications and meetings on and off-site with both internal and external attendeesPrepare all necessary documents for the evaluation of new proposals and coordinate the decision process of new AR or ISS projectsManage the grant application platform which maintains all necessary documents and the communication with PIsSet up, update, maintain and close Trial Master Files. Assure currency and accuracy of required clinical trials documents Maintain project-specific regulatory document inventory systems which include a precise quality check (QC) process when documents are receivedCommunicate with investigator sites on collection of regulatory documentsCreate study materials, including newsletters, study updates, etc. under the direction of a Scientist or Clinical Program ManagerSource and distribute study suppliesInteract with Finance departments to support invoice processingInteract with the Sales and Customer service department to support and coordinate external needs and internal processes.Under guidance of Clinical Operations management, interact with internal stakeholders and external clients to coordinate the accomplishment of business needsRequirements:BS degree or BS degreeRelevant clinical or basic research experience working at an Investigator Site, Sponsor or Clinical Research OrganizationFamiliarity of clinical trial operations, ICH, GCP Guidelines Good working experience in a team environment across multi-functional areasHighly organized, self-motivated, detail-oriented, proactive, and accurateAbility to work with urgency and thrive in a high-energy, fast-paced environmentDemonstrate excellent communication, verbal and written, and interpersonal skillsFluent in written and spoken English and GermanDemonstrate proficiency in MS Office Suite: Word, PowerPoint, Excel, Project ABIOMED is an Equal Employment Opportunity employer. We are committed to the policy of providing equal employment opportunities without regard to race, color, religion, sex, sexual orientation, gender identity, disability or national origin. Über das Unternehmen:Johnson and Johnson

Help us change livesAt Exact Sciences, we’re helping change how the world prevents, detects and guides treatment for cancer. We give patients and clinicians the clarity needed to make confident decisions when they matter most. Join our team to find a purpose-driven career, an inclusive culture, and robust benefits to support your life while you’re working to help others.Company OverviewExact Sciences is dedicated to delivering patient critical answers across the cancer journey from early detection to treatment decision making. With a strong focus on people and an empathetic spirit, which fuels the company’s culture, driving them to create and deliver solutions rooted in the needs of patients, providers, and families. From earlier cancer detection to treatment guidance and monitoring, Exact Sciences are helping people get the answers they need to make more informed decisions across the cancer continuum. With a leading portfolio of products for earlier detection and treatment guidance, they help people face the most challenging decisions with confidence with a dedication to continuously innovate, combining scientific rigor with an open-minded approach to deliver the next big thing.Exact Sciences is continuously expanding the pipeline with the aim of tackling a wider array of cancer tests through the following measures:Expanding the Oncotype IQ platform to include liquid and tissue-based tests, all with the goal of making cancer care smarter.Adapting biomarker-based technologies create a liquid biopsy capable of detecting cancers and precancers from a blood sample.Using their proven multi-marker approach to achieve analytical sensitivity needed to discriminate between normal and cancerous samples.Collaborating with world-class clinicians and scientists at Mayo Clinic to identify biomarkers associated with the 15 deadliest cancers.Building a cancer detection platform upon learnings from the development of Cologuard (commercially available in the US only).By 2020, Oncotype DX will have been used to guide treatment decisions for more than 1 million cancer patients worldwide in breast, prostate and colon cancer.In July 2019 Exact Sciences acquired Genomic Health, a genetic cancer detection company based in Redwood City, California, for USD 2.8 billion, creating the leading global cancer diagnostics company.In 2020 Exact Sciences acquired Thrive Earlier Detection Corp., a Massachusetts-based healthcare company, in a multi-billion-dollar deal, and Base Genomics, which has technology for DNA methylation analysis.In February 2021 Exact Sciences announced the acquisition of Ashion Analytics, LLC (Ashion) from The Translational Genomics Research Institute (TGen), an affiliate of City of Hope. Ashion is a CLIA-certified and CAP-accredited sequencing lab based in Phoenix, Arizona with the genomics testing capabilities necessary to address the increasingly complex needs of clinical, academic, and biopharma customers focused on precision cancer treatments.The company is based in the United States, with International headquarters in Zug, Switzerland. Position SummaryThe Medical Affairs Senior Manager, MSL & Expansion Markets, France is a hybrid role responsible for leading an international team of Medical Science Liaisons and supporting Exact Sciences International expansion strategy with key medical activities.This is an exciting chance to build the first Exact Sciences International MSL team in leading and executing an efficient and transparent conversion plan to bring MSL contractors in-house as well as hire and onboard new MSLs to create a diverse and inclusive team. The International Medical Affairs Senior Manager – MSL & Expansion Markets will be expected to develop and drive MSL strategy ensure field medical activities and insight generation result in demonstrable outcomes and further develop and grow the MSL capability at Exact Sciences International.In addition, this individual will be responsible for medical affairs activities in selected key markets across International. These markets will include those where we want to move directly into a market (currently through distributors) or those markets where we currently have limited patient access that require improved reimbursement pathways.The Medical lead will work closely with the Market Expansion Team and lead all associated medial activities that may include leading medical activities for change in market reimbursement, aligning new market needs with central medical team, developing core data strategy for new markets, and defining resourcing needs and transition to new hires. The position is also responsible for consolidating and interpreting medical intelligence and reporting it to the Expansion Markets team.The incumbent will work closely with other functions within the company, including Corporate Strategy, Marketing, and Commercial to advance cross-functional understanding of the MSL value proposition, identify gaps and achieve results in line with company objectives.Representing the medical function, this individual will also manage research and educational medical objectives, while supporting commercial business and reimbursement objectives for the Oncotype DX breast recurrence score test.This position requires professionals with established personal and scientific creditability to interact with thought leaders, government health authorities, and medical centers of excellence. This is a dynamic role and will continue to evolve.Responsibilities/DutiesLead an international team of MSLs toward the implementation of field medical activities by communicating expectations and guiding the team to maintain and effectively communicate deep scientific knowledge and excel at KOL engagement and support medical/scientific information needs of scientific and clinical experts.Accompany the team to meetings with KOLs and other HCPs to assess proficiency and provide timely and constructive performance feedback.Lead and coordinate MSL team meetings to support team building, best practice sharing, development, and the accomplishment of field medical objectives.Develop a MSL Strategic Plan as well as Medical Plan for the markets, which include plans for KOL engagement, data generation, educational and guideline initiatives and reimbursement initiatives that align with the business objectives.Identify and engage international, national, and regional thought leaders in breast cancer within assigned geographic regions to conduct scientific discussions and understand insights related to molecular diagnostics in early BC management, while also establishing and maintaining professional relationships with them.Act as primary contact for investigators interested in developing and performing studies with the company’s commercially available assays in breast cancer.Assist in R&D and investigator-initiated studies as appropriate.Lead national and regional Advisory Boards when external advice is needed.Provide clinical presentations and information in academic, community, and healthcare provider setting in both group and one-on-one situations.Support & partner with regional team to deliver key medical activities.Developing medical slides, giving medical training presentations, and training in internal meetings and for partner distributors.Support international access & reimbursement with medical and scientific expertise.Assure compliance with relevant corporate policies.Provide feedback and medical input to local commercial plans and strategies.Pivotal Experience & ExpertiseDegree in Medicine/Medical Doctor or PhD, PharmD.3+ years of therapeutic clinical experience desired.5 to 7 years of industry experience (working in pharma/biotech/med tech).At least 3 years in a Medical Science Liaison role.Previous MSL (or other) management experience.Expertise in Oncology. Experience in breast/GI/lung cancer is a plus.Experience in Diagnostics or Biotech industry is a plus.Experience in relevant geographies a plus.Excellent English. Skills in other languages preferred.Excellent oral, written and presentation communication skills.Ability to independently deliver quality results in a timely manner.Proven record of working in matrix environment and delivering as part of a cross-functional team.Track record of delivering innovative medical activities across markets.Cultural ImpactHighest integrity and ethical behavior.Mutual respect for colleagues.Collaborative within teams, uses resources carefully and can build a great place to work and grow.Ability to interact within culturally diverse teams.Business acumen and innovative mindset. Ability to manage though complexity and ambiguity, while focusing on the end goal.OtherOffice-based in the International headquarters in Zug or out of one of our European offices.Ability to travel approx.. >50%.#LI-TK1Our success relies on the experiences and perspectives of a diverse team, and Exact Sciences fosters a culture where all employees can develop personally and professionally with a sense of respect and belonging. If you require an accommodation, email E-Mail anzeigen. We’ll work with you to meet your accessibility needs.Not ready to apply? Join our talent community and stay up to date on what’s new at Exact Sciences. Standort PreventionGenetics, Düsseldorf

Help us change lives At Exact Sciences, we’re helping change how the world prevents, detects and guides treatment for cancer. We give patients and clinicians the clarity needed to make confident decisions when they matter most. Join our team to find a purpose-driven career, an inclusive culture, and robust benefits to support your life while you’re working to help others. Company Overview Exact Sciences is dedicated to delivering patient critical answers across the cancer journey from early detection to treatment decision making. With a strong focus on people and an empathetic spirit, which fuels the company’s culture, driving them to create and deliver solutions rooted in the needs of patients, providers, and families. From earlier cancer detection to treatment guidance and monitoring, Exact Sciences are helping people get the answers they need to make more informed decisions across the cancer continuum. With a leading portfolio of products for earlier detection and treatment guidance, they help people face the most challenging decisions with confidence with a dedication to continuously innovate, combining scientific rigor with an open-minded approach to deliver the next big thing. Exact Sciences is continuously expanding the pipeline with the aim of tackling a wider array of cancer tests through the following measures: Expanding the Oncotype IQ platform to include liquid and tissue-based tests, all with the goal of making cancer care smarter. Adapting biomarker-based technologies create a liquid biopsy capable of detecting cancers and precancers from a blood sample. Using their proven multi-marker approach to achieve analytical sensitivity needed to discriminate between normal and cancerous samples. Collaborating with world-class clinicians and scientists at Mayo Clinic to identify biomarkers associated with the 15 deadliest cancers. Building a cancer detection platform upon learnings from the development of Cologuard (commercially available in the US only). By 2020, Oncotype DX will have been used to guide treatment decisions for more than 1 million cancer patients worldwide in breast, prostate and colon cancer. In July 2019 Exact Sciences acquired Genomic Health, a genetic cancer detection company based in Redwood City, California, for USD 2.8 billion, creating the leading global cancer diagnostics company. In 2020 Exact Sciences acquired Thrive Earlier Detection Corp., a Massachusetts-based healthcare company, in a multi-billion-dollar deal, and Base Genomics, which has technology for DNA methylation analysis. In February 2021 Exact Sciences announced the acquisition of Ashion Analytics, LLC (Ashion) from The Translational Genomics Research Institute (TGen), an affiliate of City of Hope. Ashion is a CLIA-certified and CAP-accredited sequencing lab based in Phoenix, Arizona with the genomics testing capabilities necessary to address the increasingly complex needs of clinical, academic, and biopharma customers focused on precision cancer treatments. The company is based in the United States, with International headquarters in Zug, Switzerland. Position Summary The Medical Affairs Senior Manager, MSL & Expansion Markets, France is a hybrid role responsible for leading an international team of Medical Science Liaisons and supporting Exact Sciences International expansion strategy with key medical activities. This is an exciting chance to build the first Exact Sciences International MSL team in leading and executing an efficient and transparent conversion plan to bring MSL contractors in-house as well as hire and onboard new MSLs to create a diverse and inclusive team. The International Medical Affairs Senior Manager – MSL & Expansion Markets will be expected to develop and drive MSL strategy ensure field medical activities and insight generation result in demonstrable outcomes and further develop and grow the MSL capability at Exact Sciences International. In addition, this individual will be responsible for medical affairs activities in selected key markets across International. These markets will include those where we want to move directly into a market (currently through distributors) or those markets where we currently have limited patient access that require improved reimbursement pathways. The Medical lead will work closely with the Market Expansion Team and lead all associated medial activities that may include leading medical activities for change in market reimbursement, aligning new market needs with central medical team, developing core data strategy for new markets, and defining resourcing needs and transition to new hires. The position is also responsible for consolidating and interpreting medical intelligence and reporting it to the Expansion Markets team. The incumbent will work closely with other functions within the company, including Corporate Strategy, Marketing, and Commercial to advance cross-functional understanding of the MSL value proposition, identify gaps and achieve results in line with company objectives. Representing the medical function, this individual will also manage research and educational medical objectives, while supporting commercial business and reimbursement objectives for the Oncotype DX breast recurrence score test. This position requires professionals with established personal and scientific creditability to interact with thought leaders, government health authorities, and medical centers of excellence. This is a dynamic role and will continue to evolve. Responsibilities/Duties Lead an international team of MSLs toward the implementation of field medical activities by communicating expectations and guiding the team to maintain and effectively communicate deep scientific knowledge and excel at KOL engagement and support medical/scientific information needs of scientific and clinical experts. Accompany the team to meetings with KOLs and other HCPs to assess proficiency and provide timely and constructive performance feedback. Lead and coordinate MSL team meetings to support team building, best practice sharing, development, and the accomplishment of field medical objectives. Develop a MSL Strategic Plan as well as Medical Plan for the markets, which include plans for KOL engagement, data generation, educational and guideline initiatives and reimbursement initiatives that align with the business objectives. Identify and engage international, national, and regional thought leaders in breast cancer within assigned geographic regions to conduct scientific discussions and understand insights related to molecular diagnostics in early BC management, while also establishing and maintaining professional relationships with them. Act as primary contact for investigators interested in developing and performing studies with the company’s commercially available assays in breast cancer. Assist in R&D and investigator-initiated studies as appropriate. Lead national and regional Advisory Boards when external advice is needed. Provide clinical presentations and information in academic, community, and healthcare provider setting in both group and one-on-one situations. Support & partner with regional team to deliver key medical activities. Developing medical slides, giving medical training presentations, and training in internal meetings and for partner distributors. Support international access & reimbursement with medical and scientific expertise. Assure compliance with relevant corporate policies. Provide feedback and medical input to local commercial plans and strategies. Pivotal Experience & Expertise Degree in Medicine/Medical Doctor or PhD, PharmD. 3+ years of therapeutic clinical experience desired. 5 to 7 years of industry experience (working in pharma/biotech/med tech). At least 3 years in a Medical Science Liaison role. Previous MSL (or other) management experience. Expertise in Oncology. Experience in breast/GI/lung cancer is a plus. Experience in Diagnostics or Biotech industry is a plus. Experience in relevant geographies a plus. Excellent English. Skills in other languages preferred. Excellent oral, written and presentation communication skills. Ability to independently deliver quality results in a timely manner. Proven record of working in matrix environment and delivering as part of a cross-functional team. Track record of delivering innovative medical activities across markets. Cultural Impact Highest integrity and ethical behavior. Mutual respect for colleagues. Collaborative within teams, uses resources carefully and can build a great place to work and grow. Ability to interact within culturally diverse teams. Business acumen and innovative mindset. Ability to manage though complexity and ambiguity, while focusing on the end goal. Other Office-based in the International headquarters in Zug or out of one of our European offices. Ability to travel approx.. > 50%. #LI-TK1 Our success relies on the experiences and perspectives of a diverse team, and Exact Sciences fosters a culture where all employees can develop personally and professionally with a sense of respect and belonging. Standort Genomic Health, Inc., Munich

Help us change lives At Exact Sciences, we’re helping change how the world prevents, detects and guides treatment for cancer. We give patients and clinicians the clarity needed to make confident decisions when they matter most. Join our team to find a purpose-driven career, an inclusive culture, and robust benefits to support your life while you’re working to help others. Company Overview Exact Sciences is dedicated to delivering patient critical answers across the cancer journey from early detection to treatment decision making. With a strong focus on people and an empathetic spirit, which fuels the company’s culture, driving them to create and deliver solutions rooted in the needs of patients, providers, and families. From earlier cancer detection to treatment guidance and monitoring, Exact Sciences are helping people get the answers they need to make more informed decisions across the cancer continuum. With a leading portfolio of products for earlier detection and treatment guidance, they help people face the most challenging decisions with confidence with a dedication to continuously innovate, combining scientific rigor with an open-minded approach to deliver the next big thing. Exact Sciences is continuously expanding the pipeline with the aim of tackling a wider array of cancer tests through the following measures: Expanding the Oncotype IQ platform to include liquid and tissue-based tests, all with the goal of making cancer care smarter. Adapting biomarker-based technologies create a liquid biopsy capable of detecting cancers and precancers from a blood sample. Using their proven multi-marker approach to achieve analytical sensitivity needed to discriminate between normal and cancerous samples. Collaborating with world-class clinicians and scientists at Mayo Clinic to identify biomarkers associated with the 15 deadliest cancers. Building a cancer detection platform upon learnings from the development of Cologuard (commercially available in the US only). By 2020, Oncotype DX will have been used to guide treatment decisions for more than 1 million cancer patients worldwide in breast, prostate and colon cancer. In July 2019 Exact Sciences acquired Genomic Health, a genetic cancer detection company based in Redwood City, California, for USD 2.8 billion, creating the leading global cancer diagnostics company. In 2020 Exact Sciences acquired Thrive Earlier Detection Corp., a Massachusetts-based healthcare company, in a multi-billion-dollar deal, and Base Genomics, which has technology for DNA methylation analysis. In February 2021 Exact Sciences announced the acquisition of Ashion Analytics, LLC (Ashion) from The Translational Genomics Research Institute (TGen), an affiliate of City of Hope. Ashion is a CLIA-certified and CAP-accredited sequencing lab based in Phoenix, Arizona with the genomics testing capabilities necessary to address the increasingly complex needs of clinical, academic, and biopharma customers focused on precision cancer treatments. The company is based in the United States, with International headquarters in Zug, Switzerland. Position Summary The Medical Affairs Senior Manager, MSL & Expansion Markets, France is a hybrid role responsible for leading an international team of Medical Science Liaisons and supporting Exact Sciences International expansion strategy with key medical activities. This is an exciting chance to build the first Exact Sciences International MSL team in leading and executing an efficient and transparent conversion plan to bring MSL contractors in-house as well as hire and onboard new MSLs to create a diverse and inclusive team. The International Medical Affairs Senior Manager – MSL & Expansion Markets will be expected to develop and drive MSL strategy ensure field medical activities and insight generation result in demonstrable outcomes and further develop and grow the MSL capability at Exact Sciences International. In addition, this individual will be responsible for medical affairs activities in selected key markets across International. These markets will include those where we want to move directly into a market (currently through distributors) or those markets where we currently have limited patient access that require improved reimbursement pathways. The Medical lead will work closely with the Market Expansion Team and lead all associated medial activities that may include leading medical activities for change in market reimbursement, aligning new market needs with central medical team, developing core data strategy for new markets, and defining resourcing needs and transition to new hires. The position is also responsible for consolidating and interpreting medical intelligence and reporting it to the Expansion Markets team. The incumbent will work closely with other functions within the company, including Corporate Strategy, Marketing, and Commercial to advance cross-functional understanding of the MSL value proposition, identify gaps and achieve results in line with company objectives. Representing the medical function, this individual will also manage research and educational medical objectives, while supporting commercial business and reimbursement objectives for the Oncotype DX breast recurrence score test. This position requires professionals with established personal and scientific creditability to interact with thought leaders, government health authorities, and medical centers of excellence. This is a dynamic role and will continue to evolve. Responsibilities/Duties Lead an international team of MSLs toward the implementation of field medical activities by communicating expectations and guiding the team to maintain and effectively communicate deep scientific knowledge and excel at KOL engagement and support medical/scientific information needs of scientific and clinical experts. Accompany the team to meetings with KOLs and other HCPs to assess proficiency and provide timely and constructive performance feedback. Lead and coordinate MSL team meetings to support team building, best practice sharing, development, and the accomplishment of field medical objectives. Develop a MSL Strategic Plan as well as Medical Plan for the markets, which include plans for KOL engagement, data generation, educational and guideline initiatives and reimbursement initiatives that align with the business objectives. Identify and engage international, national, and regional thought leaders in breast cancer within assigned geographic regions to conduct scientific discussions and understand insights related to molecular diagnostics in early BC management, while also establishing and maintaining professional relationships with them. Act as primary contact for investigators interested in developing and performing studies with the company’s commercially available assays in breast cancer. Assist in R&D and investigator-initiated studies as appropriate. Lead national and regional Advisory Boards when external advice is needed. Provide clinical presentations and information in academic, community, and healthcare provider setting in both group and one-on-one situations. Support & partner with regional team to deliver key medical activities. Developing medical slides, giving medical training presentations, and training in internal meetings and for partner distributors. Support international access & reimbursement with medical and scientific expertise. Assure compliance with relevant corporate policies. Provide feedback and medical input to local commercial plans and strategies. Pivotal Experience & Expertise Degree in Medicine/Medical Doctor or PhD, PharmD. 3+ years of therapeutic clinical experience desired. 5 to 7 years of industry experience (working in pharma/biotech/med tech). At least 3 years in a Medical Science Liaison role. Previous MSL (or other) management experience. Expertise in Oncology. Experience in breast/GI/lung cancer is a plus. Experience in Diagnostics or Biotech industry is a plus. Experience in relevant geographies a plus. Excellent English. Skills in other languages preferred. Excellent oral, written and presentation communication skills. Ability to independently deliver quality results in a timely manner. Proven record of working in matrix environment and delivering as part of a cross-functional team. Track record of delivering innovative medical activities across markets. Cultural Impact Highest integrity and ethical behavior. Mutual respect for colleagues. Collaborative within teams, uses resources carefully and can build a great place to work and grow. Ability to interact within culturally diverse teams. Business acumen and innovative mindset. Ability to manage though complexity and ambiguity, while focusing on the end goal. Other Office-based in the International headquarters in Zug or out of one of our European offices. Ability to travel approx.. > 50%. #LI-TK1 Our success relies on the experiences and perspectives of a diverse team, and Exact Sciences fosters a culture where all employees can develop personally and professionally with a sense of respect and belonging. Standort Genomic Health, Inc., Cologne

Help us change lives At Exact Sciences, we’re helping change how the world prevents, detects and guides treatment for cancer. We give patients and clinicians the clarity needed to make confident decisions when they matter most. Join our team to find a purpose-driven career, an inclusive culture, and robust benefits to support your life while you’re working to help others. Company Overview Exact Sciences is dedicated to delivering patient critical answers across the cancer journey from early detection to treatment decision making. With a strong focus on people and an empathetic spirit, which fuels the company’s culture, driving them to create and deliver solutions rooted in the needs of patients, providers, and families. From earlier cancer detection to treatment guidance and monitoring, Exact Sciences are helping people get the answers they need to make more informed decisions across the cancer continuum. With a leading portfolio of products for earlier detection and treatment guidance, they help people face the most challenging decisions with confidence with a dedication to continuously innovate, combining scientific rigor with an open-minded approach to deliver the next big thing. Exact Sciences is continuously expanding the pipeline with the aim of tackling a wider array of cancer tests through the following measures: Expanding the Oncotype IQ platform to include liquid and tissue-based tests, all with the goal of making cancer care smarter. Adapting biomarker-based technologies create a liquid biopsy capable of detecting cancers and precancers from a blood sample. Using their proven multi-marker approach to achieve analytical sensitivity needed to discriminate between normal and cancerous samples. Collaborating with world-class clinicians and scientists at Mayo Clinic to identify biomarkers associated with the 15 deadliest cancers. Building a cancer detection platform upon learnings from the development of Cologuard (commercially available in the US only). By 2020, Oncotype DX will have been used to guide treatment decisions for more than 1 million cancer patients worldwide in breast, prostate and colon cancer. In July 2019 Exact Sciences acquired Genomic Health, a genetic cancer detection company based in Redwood City, California, for USD 2.8 billion, creating the leading global cancer diagnostics company. In 2020 Exact Sciences acquired Thrive Earlier Detection Corp., a Massachusetts-based healthcare company, in a multi-billion-dollar deal, and Base Genomics, which has technology for DNA methylation analysis. In February 2021 Exact Sciences announced the acquisition of Ashion Analytics, LLC (Ashion) from The Translational Genomics Research Institute (TGen), an affiliate of City of Hope. Ashion is a CLIA-certified and CAP-accredited sequencing lab based in Phoenix, Arizona with the genomics testing capabilities necessary to address the increasingly complex needs of clinical, academic, and biopharma customers focused on precision cancer treatments. The company is based in the United States, with International headquarters in Zug, Switzerland. Position Summary The Medical Affairs Senior Manager, MSL & Expansion Markets, France is a hybrid role responsible for leading an international team of Medical Science Liaisons and supporting Exact Sciences International expansion strategy with key medical activities. This is an exciting chance to build the first Exact Sciences International MSL team in leading and executing an efficient and transparent conversion plan to bring MSL contractors in-house as well as hire and onboard new MSLs to create a diverse and inclusive team. The International Medical Affairs Senior Manager – MSL & Expansion Markets will be expected to develop and drive MSL strategy ensure field medical activities and insight generation result in demonstrable outcomes and further develop and grow the MSL capability at Exact Sciences International. In addition, this individual will be responsible for medical affairs activities in selected key markets across International. These markets will include those where we want to move directly into a market (currently through distributors) or those markets where we currently have limited patient access that require improved reimbursement pathways. The Medical lead will work closely with the Market Expansion Team and lead all associated medial activities that may include leading medical activities for change in market reimbursement, aligning new market needs with central medical team, developing core data strategy for new markets, and defining resourcing needs and transition to new hires. The position is also responsible for consolidating and interpreting medical intelligence and reporting it to the Expansion Markets team. The incumbent will work closely with other functions within the company, including Corporate Strategy, Marketing, and Commercial to advance cross-functional understanding of the MSL value proposition, identify gaps and achieve results in line with company objectives. Representing the medical function, this individual will also manage research and educational medical objectives, while supporting commercial business and reimbursement objectives for the Oncotype DX breast recurrence score test. This position requires professionals with established personal and scientific creditability to interact with thought leaders, government health authorities, and medical centers of excellence. This is a dynamic role and will continue to evolve. Responsibilities/Duties Lead an international team of MSLs toward the implementation of field medical activities by communicating expectations and guiding the team to maintain and effectively communicate deep scientific knowledge and excel at KOL engagement and support medical/scientific information needs of scientific and clinical experts. Accompany the team to meetings with KOLs and other HCPs to assess proficiency and provide timely and constructive performance feedback. Lead and coordinate MSL team meetings to support team building, best practice sharing, development, and the accomplishment of field medical objectives. Develop a MSL Strategic Plan as well as Medical Plan for the markets, which include plans for KOL engagement, data generation, educational and guideline initiatives and reimbursement initiatives that align with the business objectives. Identify and engage international, national, and regional thought leaders in breast cancer within assigned geographic regions to conduct scientific discussions and understand insights related to molecular diagnostics in early BC management, while also establishing and maintaining professional relationships with them. Act as primary contact for investigators interested in developing and performing studies with the company’s commercially available assays in breast cancer. Assist in R&D and investigator-initiated studies as appropriate. Lead national and regional Advisory Boards when external advice is needed. Provide clinical presentations and information in academic, community, and healthcare provider setting in both group and one-on-one situations. Support & partner with regional team to deliver key medical activities. Developing medical slides, giving medical training presentations, and training in internal meetings and for partner distributors. Support international access & reimbursement with medical and scientific expertise. Assure compliance with relevant corporate policies. Provide feedback and medical input to local commercial plans and strategies. Pivotal Experience & Expertise Degree in Medicine/Medical Doctor or PhD, PharmD. 3+ years of therapeutic clinical experience desired. 5 to 7 years of industry experience (working in pharma/biotech/med tech). At least 3 years in a Medical Science Liaison role. Previous MSL (or other) management experience. Expertise in Oncology. Experience in breast/GI/lung cancer is a plus. Experience in Diagnostics or Biotech industry is a plus. Experience in relevant geographies a plus. Excellent English. Skills in other languages preferred. Excellent oral, written and presentation communication skills. Ability to independently deliver quality results in a timely manner. Proven record of working in matrix environment and delivering as part of a cross-functional team. Track record of delivering innovative medical activities across markets. Cultural Impact Highest integrity and ethical behavior. Mutual respect for colleagues. Collaborative within teams, uses resources carefully and can build a great place to work and grow. Ability to interact within culturally diverse teams. Business acumen and innovative mindset. Ability to manage though complexity and ambiguity, while focusing on the end goal. Other Office-based in the International headquarters in Zug or out of one of our European offices. Ability to travel approx.. > 50%. #LI-TK1 Our success relies on the experiences and perspectives of a diverse team, and Exact Sciences fosters a culture where all employees can develop personally and professionally with a sense of respect and belonging. Standort Genomic Health, Inc., Düsseldorf